Drugs / Fe-ASP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03524651 Comparator | May 2018 → Jan 2021 | iron deficiency anemia | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fe-ASP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03524651 ↗ |
| Route | Oral | “new oral formulation of Fe-ASP” NCT03524651 ↗ |